| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 13 | 22 | -0,81 % | ||
| EQT AB | 6 | 6 | +0,07 % | ||
| ERICSSON | 1 | 20 | +0,70 % | ||
| ABB | 1 | 18 | +2,50 % | ||
| NORDEA BANK | 1 | 6 | +1,51 % | ||
| SAAB | 1 | 5 | -0,33 % | ||
| TELE2 | 1 | 1 | +0,95 % | ||
| VOLVO | - | 17 | +0,14 % | ||
| SKF AB B | - | 9 | +0,09 % | ||
| HEXAGON | - | 9 | +0,41 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:30 | AstraZeneca Says Imfinzi Combination Improved Survival In Phase III Bladder Cancer Trial | 153 | AFX News | LONDON (dpa-AFX) - AstraZeneca plc (AZN) on Thursday said an interim analysis of the Phase III VOLGA trial showed that perioperative treatment with Imfinzi combined with neoadjuvant enfortumab... ► Artikel lesen | |
| 18:10 | AstraZeneca scores with Imfinzi in another bladder cancer trial, rivaling Merck's Keytruda | 4 | FiercePharma | ||
| 16:54 | Tele2 Jean Marc Harion CEO to step down after 18 months at the helm | 2 | DatacenterDynamics | ||
| 16:34 | Saab und PGZ bauen strategische Kooperation im Marinebereich aus | 2 | Militär Aktuell | ||
| 13:46 | AstraZeneca meldet positive Phase-III-Ergebnisse für Imfinzi-Kombination bei Blasenkrebs | 6 | Investing.com Deutsch | ||
| 13:38 | Brookfield set to buy World Freight Company from EQT and PAI in $1.2bn deal | 5 | Private Equity Insights | ||
| 13:25 | ASTRAZENECA PLC - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 12:25 | AstraZeneca immunotherapy for stomach cancer green lit for NHS use | 3 | Alliance News | ||
| 11:54 | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | 558 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca auf "Overweight" mit einem Kursziel von 16000 Pence belassen. Die Volga-Studie habe für das Medikament Imfinzi bei... ► Artikel lesen | |
| 11:51 | LY Corp. and Bain up Kakaku bid to $4bn, surpassing EQT offer | 2 | Private Equity Wire | ||
| 11:23 | AstraZeneca reports positive results from bladder cancer drug trial | 5 | Sharecast | ||
| 10:25 | AstraZeneca's bladder cancer drug yields encouraging test results | 3 | Alliance News | ||
| 10:06 | Intertek stock rating cut to Sector Perform by RBC on EQT bid | 3 | Investing.com | ||
| 09:58 | EQT-Übernahmeangebot: RBC stuft Intertek auf "Sector Perform" herab | 6 | Investing.com Deutsch | ||
| 09:54 | AstraZeneca Says Imfinzi Combination Improved Survival In Phase III Bladder Cancer Trial | 274 | AFX News | LONDON (dpa-AFX) - AstraZeneca plc (AZN) on Thursday said an interim analysis of the Phase III VOLGA trial showed that perioperative treatment with Imfinzi combined with enfortumab vedotin (EV)... ► Artikel lesen | |
| 09:54 | DEUTSCHE BANK RESEARCH stuft Nordea auf 'Buy' | 389 | dpa-AFX-Analyser | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Nordea von 18 auf 19 Euro angehoben und die Einstufung auf "Buy" belassen. Die nordischen Banken hätten die Erwartungen im... ► Artikel lesen | |
| 08:30 | AstraZeneca Imfinzi combo improves survival in bladder cancer study | 3 | Seeking Alpha | ||
| 08:06 | ABB is first in world to offer a magnet-free IE6 motor for hazardous areas | 285 | PR Newswire | Boosting energy efficiency in hazardous areas is critical for operators seeking to reduce their operating costs while also meeting sustainability targetsCertification to ATEX and IECEx requirements... ► Artikel lesen | |
| 08:00 | AstraZeneca PLC: Imfinzi + EV improves EFS & OS in bladder cancer | 98 | GlobeNewswire (Europe) | 14 May 2026
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder... ► Artikel lesen | |
| 04:38 | Ericsson, China Mobile & OPPO Advance Network Slicing & 5G SA Differentiated Services Testing | 6 | The Fast Mode |